Invasion of bone cells by Staphylococcus epidermidis

Area of Science:

• Orthopedics
• Microbiology
• Infectious Diseases

Background:

• Bone implant infections by Staphylococcus epidermidis (S. epidermidis) are difficult to treat with antibiotics, often necessitating surgery.
• The mechanisms behind S. epidermidis' resistance to antimicrobial therapy are not well understood.
• Previous research showed Staphylococcus aureus (S. aureus) invades bone cells, evading treatment.

Purpose of the Study:

• To investigate if S. epidermidis invades bone cells, similar to S. aureus.
• To determine if bone cell invasion explains the therapeutic difficulties associated with S. epidermidis bone infections.

Main Methods:

• Bone cells were exposed to various S. epidermidis strains to assess invasion capacity.
• The effect of a recombinant protein (S. aureus fibronectin-binding protein B D1-D4 repeat region) on S. epidermidis internalization was tested.
• The impact of a blocking antibody to alpha5beta1 integrin on S. epidermidis uptake was evaluated.

Main Results:

• S. epidermidis demonstrated the ability to invade bone cells, with notable strain-dependent variations.
• The recombinant S. aureus fibronectin-binding protein B protein did not inhibit S. epidermidis bone cell invasion.
• An antibody targeting alpha5beta1 integrin did not affect S. epidermidis internalization into bone cells.

Conclusions:

• S. epidermidis invasion of bone cells contributes to the challenges in treating bone implant infections.
• Unlike S. aureus, S. epidermidis does not utilize the fibronectin-alpha5beta1 integrin pathway for bone cell entry.
• Understanding these distinct invasion mechanisms is crucial for developing targeted therapies against S. epidermidis bone infections.